S-100β and MIA in advanced melanoma in relation to prognostic factors

S-100β and MIA in advanced melanoma in relation to prognostic factors

We compared the sensitivity and specificity of S-100 and MIA in advanced melanoma, in 96 patients with no evidence of disease (NED) and 86 patients with metastatic melanoma. Abnormal S100 (>0.2 mu g/l) and MIA (>14 ng/ml) results were found in 1.1% and 3.2% of NED patients and in 59.3% and 54....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2005-05, Vol.25 (3A), p.1779-1782
Hauptverfasser: AUGE, J. M, MOLINA, R, FILELLA, X, BOSCH, E, GONZALEZ CAO, M, PUIG, S, MALVEHY, J, CASTEL, T, BALLESTA, A. M
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Dermatology
Medical sciences
Tumors
Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We compared the sensitivity and specificity of S-100 and MIA in advanced melanoma, in 96 patients with no evidence of disease (NED) and 86 patients with metastatic melanoma. Abnormal S100 (>0.2 mu g/l) and MIA (>14 ng/ml) results were found in 1.1% and 3.2% of NED patients and in 59.3% and 54.6% of the patients with active melanoma (p
ISSN:0250-7005
1791-7530